ArticlePDF Available

Hard and Soft Tissue Evaluation of Different Socket Preservation Procedures Using Leukocyte and Platelet-Rich Fibrin: A Retrospective Clinical and Volumetric Analysis

Authors:
  • Fondazione Policlinico Universitario A. Gemelli IRCCS—Università Cattolica del Sacro Cuore

Abstract and Figures

Purpose: The extraction of a tooth is followed by hard and soft tissue changes that can compromise implant placement. The aim of the present retrospective study was to compare the clinical and radiographic outcomes of different ridge preservation procedures based on the use of leukocyte and platelet-rich fibrin (L-PRF). Materials and methods: The study population consisted of all patients who had undergone surgery from January 1, 2017 to January 1, 2018 for alveolar ridge preservation on single posterior teeth using 3 clinical protocols: L-PRF alone, L-PRF mixed with a bone xenograft, and bone xenograft alone. Clinical and radiographic measures were recorded preoperatively and at 6 months postoperatively to determine the horizontal and vertical ridge resorption. Results: A total of 45 patients were included in the present study. All the surgeries were performed successfully, and no intraoperative complications developed. The L-PRF group experienced significantly greater horizontal and vertical bone resorption. The L-PRF plus bone xenograft group had less vertical and horizontal bone resorption than the bone xenograft alone group. Statistically significant differences in postoperative pain and wound healing were observed, with the bone xenograft alone group, in particular, having higher values for pain and experiencing delayed wound healing. Conclusions: Within the limitations of the present retrospective study, the use of a bone xenograft alone or L-PRF combined with a bone xenograft to perform alveolar ridge preservation procedures significantly limited bone resorption.
Content may be subject to copyright.
Hard and Soft Tissue Evaluation of
Different Socket Preservation
Procedures Using Leukocyte and
Platelet-Rich Fibrin: A Retrospective
Clinical and Volumetric Analysis
Paolo De Angelis, DDS,
*
Silvio De Angelis, DDS,
y
Pier Carmine Passarelli, DDS,
z
Margherita Giorgia Liguori, DDS,
x
Paolo Francesco Manicone, DDS,
jj
and
Antonio D’Addona, DDS, MSc
{
Purpose: The extraction of a tooth is followed by hard and soft tissue changes that can compromise
implant placement. The aim of the present retrospective study was to compare the clinical and radio-
graphic outcomes of different ridge preservation procedures based on the use of leukocyte and
platelet-rich fibrin (L-PRF).
Materials and Methods: The study population consisted of all patients who had undergone surgery
from January 1, 2017 to January 1, 2018 for alveolar ridge preservation on single posterior teeth using 3
clinical protocols: L-PRF alone, L-PRF mixed with a bone xenograft, and bone xenograft alone. Clinical
and radiographic measures were recorded preoperatively and at 6 months postoperatively to determine
the horizontal and vertical ridge resorption.
Results: A total of 45 patients were included in the present study. All the surgeries were performed suc-
cessfully, and no intraoperative complications developed. The L-PRF group experienced significantly
greater horizontal and vertical bone resorption. The L-PRF plus bone xenograft group had less vertical
and horizontal bone resorption than the bone xenograft alone group. Statistically significant differences
in postoperative pain and wound healing were observed, with the bone xenograft alone group, in partic-
ular, having higher values for pain and experiencing delayed wound healing.
*Resident, Division of Oral Surgery and Implantology,
Department of Head and Neck, Oral Surgery, and Implantology
Unit, Institute of Clinical Dentistry, Fondazione Policlinico
Universitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro
Cuore, Rome, Italy.
yPrivate Practitioner, Private Dental Practice, Ascoli Piceno, Italy.
zResident, Division of Oral Surgery and Implantology,
Department of Head and Neck, Oral Surgery, and Implantology
Unit, Institute of Clinical Dentistry, Fondazione Policlinico
Universitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro
Cuore, Rome, Italy.
xPrivate Practitioner, Division of Oral Surgery and Implantology,
Department of Head and Neck Oral Surgery, and Implantology
Unit, Institute of Clinical Dentistry, Fondazione Policlinico
Universitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro
Cuore, Rome, Italy.
kProfessor, Division of Oral Surgery and Implantology,
Department of Head and Neck Oral Surgery, and Implantology
Unit, Institute of Clinical Dentistry, Fondazione Policlinico
Universitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro
Cuore, Rome, Italy.
{Department Head, Division of Oral Surgery and Implantology,
Department of Head and Neck Oral Surgery, and Implantology
Unit, Institute of Clinical Dentistry, Fondazione Policlinico
Universitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro
Cuore, Rome, Italy.
Conflict of Interest Disclosures: None of the authors have any
relevant financial relationship(s) with a commercial interest.
Address correspondence and reprint requests to Dr De Angelis:
Division of Oral Surgery and Implantology, Department of Head
and Neck, Institute of Clinical Dentistry, Fondazione Policlinico Uni-
versitario A. Gemelli IRCCS—Universit
a Cattolica del Sacro Cuore,
Largo Francesco Vito 1, Rome 00168, Italy; e-mail: dr.
paolodeangelis@gmail.com
Received March 7 2019
Accepted May 6 2019
Ó2019 American Association of Oral and Maxillofacial Surgeons
0278-2391/19/30535-X
https://doi.org/10.1016/j.joms.2019.05.004
1807
Conclusions: Within the limitations of the present retrospective study, the use of a bone xenograft alone
or L-PRF combined with a bone xenograft to perform alveolar ridge preservation procedures significantly
limited bone resorption.
Ó2019 American Association of Oral and Maxillofacial Surgeons
J Oral Maxillofac Surg 77:1807-1815, 2019
The alveolar bone is a tissue strictly dependent on the
tooth and the periodontal ligament.
1
After tooth
extraction, hard and soft tissue changes should be
expected at the surgical site.
2,3
Also, even in the
absence of any complications developing during the
postoperative phase, it will not be possible to
maintain the preoperative bone volume.
1
The bundle
bone is the inner part of the alveolus,
2
and postopera-
tive changes will be triggered by its resorption, which
results from the loss of blood support deriving from
the periodontal ligament.
3,4
The dimensional
changes that occur during the healing phase will
cause a significant reduction in width that will be
greater than the loss in height.
Furthermore, the width reduction can reach 50% at
1 year in the premolar and molar areas, and 75% of the
final changes will usually occur within the first
3 months.
1,5
The postoperative hard and soft tissue
alterations can cause difficulties in implant
placement, especially when a prosthetically driven
and aesthetic rehabilitation is desired.
2,6
Therefore,
different regenerative procedures have been
proposed to counteract the hard and soft tissue
changes. These procedures have included the
flapless approach,
7,8
immediate implant placement,
9
and ridge preservation procedures using a combina-
tion of various surgical techniques and biomate-
rials.
7,8,10
Numerous ridge preservation procedures
with different degrees of success have been
described, including the use of autografts, allografts,
alloplasts, and xenografts, which can be combined
with resorbable or nonresorbable membranes.
11,12
However, no guidelines have been reported
regarding which type of biomaterial or surgical
procedure would be best.
10,13
Platelet concentrates have long been applied in
dentistry with the purpose of inducing tissue regener-
ation to take advantage of the supraphysiological
doses of autologous growth factors released.
13
Leuko-
cyte and platelet-rich fibrin (L-PRF) is created without
anticoagulants and was developed in 2001 as an
improved formulation of PRP to avoid the formation
of a fibrin clot and eliminate leukocytes from the final
blood concentrates.
13,14
L-PRF acts as an ideal
postextraction material by improving bone healing
and reducing the risk of infection. However, a
limited number of studies have been reported on
this subject; thus, the necessity exists to further
evaluate the outcomes of L-PRF use in
postextraction sockets.
13
The aim of the present study was to compare the
clinical and radiographic outcomes of different ridge
preservation procedures according to the use of
L-PRF within the first 6 months after tooth extraction.
Materials and Methods
The present study was designed as a retrospective
comparative study to evaluate different socket preser-
vation procedures performed before implant place-
ment. The study population consisted of all patients
who had undergone surgery from January 1, 2017 to
January 1, 2018 in a periodontal private practice for
alveolar ridge preservation on single posterior teeth
using 3 clinical protocols: L-PRF alone, L-PRF mixed
with a bone xenograft, and a bone xenograft alone.
Patients were preoperatively assigned to 1 of these 3
groups. The decision to perform 1 of these 3 protocols
was made after a discussion with the patient and a
review of their preoperative clinical and radiographic
evaluation data. Those patients who had refused to
receive a bone xenograft were treated using only
L-PRF. Those patients who had refused to undergo
blood collection were treated using only a bone xeno-
graft. Finally, those patients who had agreed to receive
a bone xenograft and who had undergone blood
collection were treated using L-PRF and a
bone xenograft.
The present study was conducted in private prac-
tice, and the medical devices evaluated had already
been approved for clinical use. All investigations
reported were performed in accordance with the
1975 Declaration of Helsinki, as revised in 2013, for
ethical approval. All the participants had provided
written informed consent after receiving explanations
of the study objectives and procedures. Because of the
retrospective nature of our study, the local institu-
tional review board had granted an exemption
in writing.
The inclusion criteria were as follows: 1) the need
for 1 or more extractions in the upper or lower
jaw, 2) the need for 1 or more implants in the upper
or lower jaw, 3) sufficient vertical and horizontal
bone dimensions, and 4) all extraction sites had adja-
cent teeth present. The diagnosed indications for
tooth extractions were caries, endodontic
1808 EVALUATION OF DIFFERENT SOCKET PRESERVATION PROCEDURES
complications (eg, root fracture), periodontitis, or
other prosthetic reasons. Only healthy patients with
adequate oral hygiene were included. The participants
were required to have a full-mouth plaque score and
full-mouth bleeding score less than 15%.
Patients with acute periodontal or periapical infec-
tions were excluded. In addition, patients were
excluded because of the following contraindications:
1) a general contraindication for bone augmentation
procedures and/or surgical treatment; 2) uncontrolled
periodontal disease; 3) immunosuppressant, cortico-
steroid, or bisphosphonate therapy; 4) a history of
malignancy, radiotherapy, or chemotherapy for malig-
nancy within the previous 5 years; 5) smoker; 6)
blood-related disease; and 7) an unwillingness to
return for the follow-up examinations. However,
patients with sites with a loss of the buccal or palatal
bone plate (<50% of the initial height) were included.
The sockets were carefully cleaned and treated
using 1 of the following: L-PRF; L-PRF mixed with
a bone xenograft (L-PRF plus Bio-Oss; Geistlich
Pharma AG, Wolhusen, Switzerland); or bone xeno-
graft (Bio-Oss Collagen; Geistlich Pharma AG).
The patients’ age, sex, number and type of technical
and biological complications, and the aesthetic out-
comes were recorded. The baseline findings were
considered before tooth extraction. Every patient un-
derwent radiologic examinations before surgery to
allow for preoperative planning. A preoperative
cone-beam computed tomography (CT) scan was
also performed for evaluation of the bone height and
thickness of the cortical plates.
The primary outcomes measure was defined as the
dimensional changes in the ridge width and height at
6 months after the procedure. A cone-beam CT scan
was taken at 6 months postoperatively with a resolu-
tion of 100 mm (Orthophos XG 3D; Dentsply Sirona,
York, PA). The horizontal ridge width was measured
at 3 levels: 1, 3, and 5 mm below the most coronal
aspect of the crest (HW-1, HW-3, and HW-5, respec-
tively). Vertical resorption was assessed by measuring
the height of the alveolus at the midbuccal and midlin-
gual aspects.
The volumetric changes in the soft tissues were
assessed at baseline and at 6 months after surgery by
taking impressions of the site using A-silicone impres-
sion material (Persident; Coltene/Whaledent, Altst
at-
ten, Switzerland). The site included 2 neighboring
teeth and the mucosa. Dental stone casts were fabri-
cated and optically scanned (inEos X5; Dentsply
Sirona). Next, the obtained files were imported into
a digital imaging software program.
The width of the keratinized tissue was assessed at
baseline and 6 months after the procedure. Also, the
plaque index (PI), gingival index, probing depth, and
bleeding on probing (BOP) were measured at the
tooth sites adjacent to the treatment areas to evaluate
soft tissue inflammation. The occurrence of adverse
events (eg, wound infection, exposure of the graft
and soft tissue dehiscence, necrosis) was recorded at
weeks 1, 2, and 3 and months 1, 3, and 6 after surgery.
The subjects’ overall postoperative pain was
assessed for the first 7 days using a visual analog scale
(VAS). The answers were recorded using a hash mark
on a non-numeric 100-mm line, with no pain marked
as 0 and the highest level of pain as 100. Wound heal-
ing was assessed using the Landry, Turnbull, and How-
ley index (HI). The score ranged from 1 to 5 points,
with 1 point indicating very poor healing and 5 points
indicating excellent healing. Recordings of the HI
were performed every 7 days for the first 3 weeks.
CLINICAL PROCEDURES
Before starting the surgical procedures, all the
subjects had undergone periodontal procedures to
establish adequate oral hygiene conditions. Teeth
were extracted under local anesthesia. A flapless
approach was performed as atraumatically as possible
using periotomes. After using periotomes, the teeth
were carefully extracted using extraction forceps. If
necessary, the teeth were sectioned to allow for atrau-
matic extraction. After tooth extraction, debridement
of the adjacent tooth surfaces, careful removal of gran-
ulation tissue with manual instruments, and rinsing
with sterile saline were performed.
Patient blood samples were obtained during surgery
but before tooth extraction. The blood samples were
collected and processed for L-PRF centrifugation. A to-
tal of 9 mL of whole blood without anticoagulants was
centrifuged using a sterile glass-coated plastic tube
(2700 rpm for 12 minutes; IntraSpin System; Intra-
Lock International, Boca Raton, FL). After centrifuga-
tion, each L-PRF clot was removed from the tube and
separated from the red element phase. Four L-PRF
clots were squeezed between a sterile glass plate and
a metal box to obtain L-PRF membranes that were
equal in size and thickness (Fig 1).
For the group of patients who received L-PRF mixed
with a bone xenograft, 2 PRF clots were placed in ster-
ile cups, cut into small pieces, and mixed with depro-
teinized bovine bone mineral (Geistlich Bio-Oss small
particles; Geistlich Pharma AG) at a ratio of 1 mem-
brane to 0.25 g of biomaterial (a 50:50 ratio). The
mixture obtained constituted an easy-to-use homoge-
neous graft material. Liquid fibrinogen was added to
the homogeneous mix and stirred gently for
10 seconds. The L-PRF mixed with the bone xeno-
graft was packed into the socket to at least the level
of the palatal/lingual bone plate (Fig 2).
The internal marginal gingiva of the extraction
socket was de-epithelialized using a diamond burr.
DE ANGELIS ET AL 1809
Next, a mucoperiosteal envelope was created by
detaching the soft tissues from the oral and buccal sides
of the alveolar ridge to insert 2 L-PRF membranes under
the periosteum and seal the socket from soft tissue
ingrowth (Fig 3). Finally, mattress sutures were placed
to stabilize the graft (5-0 polytetrafluoroethylene
[PTFE] sutures; Omnia S.p.A., Fidenza, Italy; Fig 4).
For the group treated with L-PRF alone, the mem-
branes were inserted into the alveolar socket and
gently compressed to at least the level of the palatal/
lingual bone plate. A mucoperiosteal envelope was
created, detaching the soft tissues from the oral and
buccal sides of the alveolar ridge to insert 2 L-PRF
membranes under the periosteum and seal the socket
from soft tissue ingrowth. Finally, mattress sutures
were placed to stabilize the graft (5-0 PTFE sutures;
Omnia S.p.A.).
For the bone xenograft alone group, deproteinized
collagen-coated bovine bone mineral (Geistlich Bio-
Oss Collagen; Geistlich Pharma AG). was packed into
the socket. Subsequently, the soft tissue borders of
the alveolus were de-epithelialized using a diamond
drill under copious irrigation with water. Finally,
mattress sutures were placed to stabilize the graft
(5-0 PTFE sutures; Omnia S.p.A.).
Antibiotic therapy with 1 g of amoxicillin was pre-
scribed every 12 hours for 6 days. The patients were
instructed to rinse every 8 hours with a 0.2% chlorhex-
idine mouth rinse and to take ibuprofen 600 mg every
12 hours for 3 days. All the patients returned at 7 and
14 days postoperatively for examination and at 21 days
for suture removal. The patients then followed their in-
dividual maintenance program according to their indi-
vidual periodontal and caries risk assessment. The
patients agreed not to wear any prostheses during
the healing period.
STATISTICAL ANALYSIS
Descriptive statistics were used to indicate the
mean, median, minimum, maximum, and standard
FIGURE 2. Leukocyte and platelet-rich fibrin mixed with the bone xenograft and packed into the socket.
De Angelis et al. Evaluation of Different Socket Preservation Procedures. J Oral Maxillofac Surg 2019.
FIGURE 3. Placement of 2 leukocyte and platelet-rich fibrin mem-
branes under the periosteum to seal the socket.
De Angelis et al. Evaluation of Different Socket Preservation Pro-
cedures. J Oral Maxillofac Surg 2019.
FIGURE 1. Leukocyte and platelet-rich fibrin clots squeezed be-
tween a sterile glass plate and a metal box.
De Angelis et al. Evaluation of Different Socket Preservation Pro-
cedures. J Oral Maxillofac Surg 2019.
1810 EVALUATION OF DIFFERENT SOCKET PRESERVATION PROCEDURES
deviation values for each treatment group. The data
were analyzed using 1-way analysis of variance (Statis-
tical Package for the Social Sciences, version 10, soft-
ware; IBM Corp., Armonk, NY). A Pvalue of < 0.05
was selected to indicate statistical significance.
Results
A total of 45 patients were included in the present
study. Of the 45 patients, 15 each were included in
the 3 groups. In the L-PRF group, the mean patient
age was 51.2 13.2 years, and 10 were women and
5 were men. In the L-PRF plus bone xenograft group,
the mean patient age was 52.4 16.6 years, and 7
were women and 8 were men. Finally, in bone xeno-
graft only group, the mean patient age was
47.7 9.1 years, and 9 were women and 6 were
men. The teeth in the present study were extracted
because of crown or root fractures in 26 patients
(58%), trauma in 4 (9%), destructive carious lesions
in 10 (22%), endodontic complications in 3 (7%),
and external root resorption in 2 (4%). All the surgeries
were successfully performed, and no intraoperative
complications were recorded. None of the patients
had presented with biological complications or signs
of periapical radiolucency at 6 months after surgery.
The baseline clinical parameters were comparable
among all 3 groups, with no statistically significant dif-
ferences (P> .05). At 6 months postoperatively, a sta-
tistically significant reduction in BOP and PI was
recorded in all groups compared with the baseline
evaluation (P< .05). The statistical comparison of clin-
ical parameters revealed no significant differences
among the 3 groups (P> .05). No statistically signifi-
cant differences in the postoperative width of the ker-
atinized mucosa were observed among the 3 groups
(P> .05). The bone volume of all sites allowed for
placement of the planned implants.
The change in the horizontal ridge width from
baseline to 6 months after surgery was statistically
significant in all 3 groups analyzed at HW-1, HW-3,
and HW-5 (P< .05). However, the L-PRF group expe-
rienced significantly greater horizontal width resorp-
tion, with a mean change at HW-1 of 2.8 0.31 mm.
The L-PRF plus bone xenograft group, with a mean
FIGURE 4. Sutures placed to stabilize the graft.
De Angelis et al. Evaluation of Different Socket Preservation Pro-
cedures. J Oral Maxillofac Surg 2019.
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
2.8
3
3.2
3.4
123456789101112131415
Patients
Mean postoperative change at HW-1
PRF
B
PRF+B
FIGURE 5. Mean change in the horizontal ridge width measured 1 mm below the most coronal aspect of the crest (HW-1).
De Angelis et al. Evaluation of Different Socket Preservation Procedures. J Oral Maxillofac Surg 2019.
DE ANGELIS ET AL 1811
change of 1.05 0.23 mm, experienced less width
resorption than did the bone xenograft group
(mean change, 1.12 0.28 mm). However, the dif-
ference was not statistically significant (P= .44;
Fig 5). The L-PRF group had also had significantly
greater horizontal width resorption at HW3 and
HW5 (P< .05; Fig 6).
The differences in the vertical ridge changes of the
buccal and lingual/palatal plates from baseline to
6 months after surgery were statistically significant
in all 3 groups (P< .05). However, the L-PRF group
experienced significantly greater vertical ridge resorp-
tion of the buccal and lingual/palatal plates, with a
mean change of 2.24 0.66 mm and
1.54 0.53 mm, respectively. The L-PRF plus bone
xenograft group had less vertical resorption on the
buccal and lingual/palatal plates, with a mean change
of 0.58 0.25 mm and 0.42 0.48 mm, respectively.
However, no statistically significant difference was
observed in the lingual/palatal plate (P< .05) or in
the buccal bone plate in the bone xenograft group
(P> .05; Figs 7, 8). A statistically significant
difference in the soft tissue thickness was observed
in the group treated with the L-PRF alone, with the
patients in this group showing greater
thickness (P< .05).
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1 2 3 4 5 6 7 8 9 101112131415
Patients
Mean postoperative change at HW-3
PRF
B
PRF+B
FIGURE 6. Mean change in the horizontal ridge width measured 3 mm below the most coronal aspect of the crest (HW-3).
De Angelis et al. Evaluation of Different Socket Preservation Procedures. J Oral Maxillofac Surg 2019.
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
2.8
3
123456789101112131415
Patients
Mean postoperative change at MB
PRF
B
LPRF+B
FIGURE 7. Mean vertical change measured at the midbuccal aspect.
De Angelis et al. Evaluation of Different Socket Preservation Procedures. J Oral Maxillofac Surg 2019.
1812 EVALUATION OF DIFFERENT SOCKET PRESERVATION PROCEDURES
Statistically significant differences in postoperative
pain sensation were observed at days 2, 3, 4, and 5
(P< .05). The bone xenograft group, in particular,
had greater pain scores on the VAS. Statistically signif-
icant differences in postoperative wound healing were
observed for the first 3 weeks in the L-PRF and L-PRF
plus bone xenograft groups, with a trend found to-
ward a greater degree of healing in both groups
compared with the bone xenograft group (P< .05).
In the bone xenograft group, 2 cases of delayed heal-
ing were noted.
Discussion
The results of the present study have demonstrated
that the use of L-PRF combined with a bone xenograft
resulted in significantly better clinical and radio-
graphic outcomes compared with those obtained
using only L-PRF or a bone xenograft.
Socket preservation procedures aim to minimize the
resorption of the ridge and maximize bone regenera-
tion within the alveolus to facilitate implant placement
in a prosthetically driven position or to maintain an
acceptable ridge contour in areas of aesthetic
concern.
12,15
The application of a slowly resorbing
grafting material could counteract, to some extent,
the ridge resorption, and that combined with L-PRF
seems to be an ideal example of guided tissue
engineering because it will act as an autologous
blood-derived scaffold.
16
Platelets are the first cells re-
cruited to the site of injury and have generally been
considered to be important in the wound healing pro-
cess. However, Bielecki et al
17
observed that the rates
of wound re-epithelialization, collagen synthesis, and
angiogenesis and the level of growth factors were
nearly identical for thrombocytopenic mice compared
with control mice. These results suggest that other
cells, such as leukocytes, have a role in the wound
healing process.
17
The L-PRF has strong fibrin poly-
merization, with leukocytes, especially lymphocytes,
enmeshed in the dense fibrin matrix.
17
These cells
are beneficial, not only because of their immune and
antibacterial potential, but also because they are the
mainstay of the wound healing process.
17
The ratio-
nale for using L-PRF is the delivery of blood compo-
nents at an early stage of healing, which diminishes
the noxious phases, regulates inflammation, promotes
vascularization, provides a matrix for cells, and
improves the regeneration of tissue and bone.
18
After
centrifugation, the L-PRF clot will contain nearly all
platelets and more than 50% of the leukocytes (most
of the lymphocytes) from the initial blood sample.
18-
20
In vitro studies revealed that L-PRF progressively
releases a significant amount of growth factors,
including transforming growth factor-b1, platelet-
derived growth factor AB, vascular endothelial growth
factor, insulin-like growth factor, matrix glycoproteins
(ie, thrombospondin-1, fibronectin, vitronectin), and
sequences of cytokines for at least 7 days.
18-20
In
addition, L-PRF is able to stimulate for at least
28 days the proliferation of different cell lines,
including bone cells (ie, fibroblasts,
prekeratinocytes, preadipocytes, osteoblasts,
mesenchymal stem cells).
18-20
L-PRF has many applications; however, clear proto-
cols are necessary to compare the outcomes and stan-
dardize all the parameters, such as the number of clots
used, amount of blood taken to prepare L-PRF, type of
centrifuge used, and centrifugation protocol.
20,21
The
different protocols of centrifugation allow us to obtain
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
2.8
3
1 2 3 4 5 6 7 8 9 101112131415
Patients
Mean postoperative change at ML
PRF
B
PRF+B
FIGURE 8. Mean vertical change measured at the midlingual aspect.
De Angelis et al. Evaluation of Different Socket Preservation Procedures. J Oral Maxillofac Surg 2019.
DE ANGELIS ET AL 1813
various types of platelet concentrates such as PRP,
L-PRF, advanced platelet-rich fibrin (A-PRF), and inject-
able platelet-rich fibrin, all of which have specific
behaviors. Although the standard L-PRF is centrifuged
at 2700 rpm for 12 minutes, the A-PRF is centrifuged at
a slower speed (1500 rpm for 14 minutes). The slower
speed results in an increase in platelet cell numbers
and an enhanced presence of neutrophilic granulo-
cytes in the distal part of the clot, which might
contribute to the differentiation of monocytes into
macrophages.
16,22
Macrophages are able to increase
osteoblast differentiation and play a key role in
promoting biomaterial integration and new bone
formation.
22
Kobayashi et al
23
investigated the growth
factors released over time, with the results indicating
that PRP demonstrated the ability to release signifi-
cantly greater levels of growth factors very early in
the healing process. In contrast, the use of PRF and
A-PRF resulted in a more gradual release of growth fac-
tors for up to 10 days, with A-PRF showing signifi-
cantly greater growth factor release over time, which
could be clinically beneficial.
23
A systematic review by Tan et al revealed that the
horizontal dimensional reduction (3.79 0.23 mm)
was greater than the vertical reduction
(1.24 0.11 mm, 0.84 0.62 mm, and
0.80 0.71 mm) at the buccal, mesial, and distal sites,
respectively, at 6 months after tooth extraction. The
proportion of vertical dimensional change was 11 to
22% at 6 months, and the proportion of horizontal
dimensional change was 32% at 3 months and 29 to
63% at 6 to 7 months.
24
The L-PRF group revealed a mean vertical bone loss
of 19.9% for the buccal bone plate and 14.6% for the
lingual/palatal bone plate. The horizontal dimensional
change at HW1 was 38.3%. The L-PRF plus bone xeno-
graft group had smaller dimensional changes in the
horizontal (18.9%) and vertical (11.42%) dimensions.
However, none of the procedures used in the 3 groups
in the present study were able to entirely compensate
for the alterations that occurred after tooth extrac-
tion.
7,8,15
The soft tissue changes demonstrated a
gain in thickness at 6 months on the buccal and
lingual aspects in all 3 groups. The horizontal
dimensional changes in the hard and soft tissue were
more substantial than were the vertical changes
during the observation period of 6 months. The
bone dimensional changes have not been the only
parameters investigated in reported data. In a study
by Hauser et al,
11
L-PRF membranes placed in the
socket were associated with improved alveolar bone
healing and better preservation of the bone volume
and architecture, with a greater degree of bone tissue
quality. Furthermore, L-PRF can remain exposed in the
oral cavity, creating accelerated tissue cicatrization by
its function in immune control, circulating stem cell
trapping, angiogenesis, and wound-covering epitheli-
alization.
11
Thus, L-PRF can be used to create a regen-
eration room sealed from the oral cavity, which avoids
an open healing state and the loss of biomaterials. Jung
et al
25
hypothesized that open healing after an alveolar
ridge preservation procedure could affect the out-
comes negatively. Data comparing socket seal surgery
have rarely been reported.
26
Brkovic et al
27
compared
the effects of applying an adjunctive resorbable dense
collagen membrane to bone substitutes. However,
they found no significant differences in the horizontal
and vertical changes after 9 months.
27
Meloni et al
26
compared the use of a porcine collagen matrix with
that of an epithelial connective tissue graft, with
similar outcomes found. However, the investigators
noted that the use of a membrane allowed for simplifi-
cation of the treatment for both patients and surgeons
by avoiding the need to harvest from the palate.
26
Bar-
one et al
28
reported that less vertical resorption
occurred using a flapped approach with a resorbable
membrane and primary closure versus a flapless
approach with a resorbable membrane left exposed.
Mean vertical bone changes of 0.6 mm 0.7 mm
and 1.1 mm 0.9 mm were recorded for the flapped
and flapless approach, respectively.
28
Furthermore,
the secondary wound healing with the flapless
approach appeared to be slower than the primary
healing with the flapped approach, despite the pres-
ence of the 2 release incisions.
28
The investigators sup-
posed the existence of a negative effect of secondary
closure related to the difficulty in cleaning the postex-
traction area with an exposed membrane in place,
which probably played a role in the greater resorp-
tion.
28
These results have been confirmed by those
from the present study. We showed that the use of
L-PRF to seal the socket promoted healing, reducing
the discomfort perceived by the patients, and avoiding
the harvesting procedures and the use of a membrane,
which were substituted for by the use of these autolo-
gous and bioactive matrices. Another important aspect
of L-PRF is related to the presence of high concentra-
tions of leukocytes, which prevent pathogens from
infiltrating. Therefore, L-PRF can be placed into the
extraction sockets, which will limit the rate of compli-
cations and infections.
22,29
Furthermore, L-PRF used as
an adjunct to a bone graft will enhance the graft
volume without interfering with bone maturation.
30
A systematic review and meta-analysis by Avila Ortiz
showed that flap elevation, the use of a membrane,
and the application of a xenograft or an allograft can
contribute to enhancing the outcomes, especially for
midbuccal and midlingual height preservation. Never-
theless, a certain degree of ridge volume loss should be
expected, although alveolar ridge preservation could
result in the maintenance of sufficient bone volume
to place an implant in an ideal restorative position,
1814 EVALUATION OF DIFFERENT SOCKET PRESERVATION PROCEDURES
avoiding other ancillary implant site development
procedures.
31
Clinical studies are required to evaluate
and compare the use of L-PRF and different bone graft
material combinations for bone regeneration proced-
ures.
32
The limitations of the present study included
the lack of randomization, low number of included pa-
tients, and the absence of a histological analysis.
Future studies should account for these limitations.
In conclusion, within the limitations of our study,
we have shown that the use of a bone xenograft alone
or the use of L-PRF combined with a bone xenograft
for performing alveolar ridge preservation procedures
significantly limited bone resorption. Furthermore,
the use of L-PRF alone or combined with a bone xeno-
graft resulted in less postoperative discomfort and
pain and better postoperative progress and healing
for the patients.
References
1. Van der Weijden F, Dell’Acqua F, Slot DE: Alveolar bone dimen-
sional changes of post-extraction sockets in humans: A system-
atic review. J Clin Periodontol 36:1048, 2009
2. Jung RE, Ioannidis A, H
ammerle CHF, Thoma DS: Alveolar ridge
preservation in the esthetic zone. Periodontol 2000 77:165,
2018
3. Cardaropoli D, Tamagnone L, Roffredo A, et al: Socket preserva-
tion using bovine bone mineral and collagen membrane: A ran-
domized controlled clinical trial with histologic analysis. Int J
Periodontics Restorative Dent 32:421, 2012
4. Chappuis V, Ara
ujo MG, Buser D: Clinical relevance of dimen-
sional bone and soft tissue alterations post-extraction in esthetic
sites. Periodontol 2000 73:73, 2017
5. Schropp L, Wenzel A, Kostopoulos L, Karring T: Bone healing
and soft tissue contour changes following single-tooth extrac-
tion: A clinical and radiographic 12-month prospective study.
Int J Periodontics Restorative Dent 23:313, 2003
6. Barone A, Aldini NN, Fini M, et al: Xenograft versus extraction
alone for ridge preservation after tooth removal: A clinical and
histomorphometric study. J Periodontol 79:1370, 2008
7. Fickl S, Zuhr O, Wachtel H, et al: Hard tissue alterations after
socket preservation: An experimental study in the beagle dog.
Clin Oral Implants Res 19:1111, 2008
8. Fickl S, Zuhr O, Wachtel H, et al: Dimensional changes of the
alveolar ridge contour after different socket preservation tech-
niques. J Clin Periodontol 35:906, 2008
9. Paolantonio M, Dolci M, Scarano A, et al: Immediate implanta-
tion in fresh extraction sockets: A controlled clinical and histo-
logical study in man. J Periodontol 72:1560, 2001
10. Vignoletti F, Matesanz P, Rodrigo D, et al: Surgical protocols for
ridge preservation after tooth extraction: A systematic review.
Clin Oral Implants Res 23(Suppl 5):22, 2012
11. Hauser F, Gaydarov N, Badoud I, et al: Clinical and histological
evaluation of postextraction platelet-rich fibrin socket filling: A
prospective randomized controlled study. Implant Dent 22:
295, 2013
12. Temmerman A, Vandessel J, Castro A, et al: The use of leucocyte
and platelet-rich fibrin in socket management and ridge preser-
vation: A split-mouth, randomized, controlled clinical trial. J Clin
Periodontol 43:990, 2016
13. Miron RJ, Zucchelli G, Pikos MA, et al: Use of platelet-rich fibrin
in regenerative dentistry: A systematic review. Clin Oral Investig
21:1913, 2017
14. Choukroun J, Ghanaati S: Reduction of relative centrifugation
force within injectable platelet-rich-fibrin (PRF) concentrates ad-
vances patients’ own inflammatory cells, platelets and growth
factors: The first introduction to the low speed centrifugation
concept. Eur J Trauma Emerg Surg 44:87, 2018
15. Mardas N, Chadha V, Donos N: Alveolar ridge preservation with
guided bone regeneration and a synthetic bone substitute or a
bovine-derived xenograft: A randomized, controlled clinical
trial. Clin Oral Implants Res 21:688, 2010
16. Ghanaati S, Booms P, Orlowska A, et al: Advanced platelet-rich
fibrin: A new concept for cell-based tissue engineering by means
of inflammatory cells. J Oral Implantol 40:679, 2014
17. Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A: The
role of leukocytes from L-PRP/L-PRF in wound healing and im-
mune defense: New perspectives. Curr Pharm Biotechnol 13:
1153, 2012
18. Ghanaati S, Herrera-Vizcaino C, Al-Maawi S, et al: Fifteen years of
platelet rich fibrin (PRF) in dentistry and oromaxillofacial sur-
gery: How high is the level of scientific evidence? J Oral Implan-
tol 44:471, 2018
19. Pinto NR, Ubilla M, Zamora Y, et al: Leucocyte- and platelet-rich
fibrin (L-PRF) as a regenerative medicine strategy for the treat-
ment of refractory leg ulcers: A prospective cohort study. Plate-
lets 29:468, 2018
20. Dohan Ehrenfest DM, Pinto NR, Pereda A, et al: The impact of
the centrifuge characteristics and centrifugation protocols on
the cells, growth factors, and fibrin architecture of a leukocyte-
and platelet-rich fibrin (L-PRF) clot and membrane. Platelets 29:
171, 2018
21. Castro AB, Meschi N, Temmerman A, et al: Regenerative poten-
tial of leucocyte- and platelet-rich fibrin. Part A: Intra-bony de-
fects, furcation defects and periodontal plastic surgery. A
systematic review and meta-analysis. J Clin Periodontol 44:67,
2017
22. Fujioka-Kobayashi M, Miron RJ, Hernandez M, et al: Optimized
platelet-rich fibrin with the low-speed concept: Growth factor
release, biocompatibility, and cellular response. J Periodontol
88:112, 2017
23. Kobayashi E, Fluckiger L, Fujioka-Kobayashi M, et al: Compara-
tive release of growth factors from PRP, PRF, and advanced-
PRF. Clin Oral Investig 20:2353, 2016
24. Tan WL, Wong TL, Wong MC, Lang NP: A systematic review of
post-extractional alveolar hard and soft tissue dimensional
changes in humans. Clin Oral Implants Res. 23(Suppl 5):1–21,
2012 Feb
25. Jung RE, Philipp A, Annen BM, et al: Radiographic evaluation of
different techniques for ridge preservation after tooth extrac-
tion: A randomized controlled clinical trial. J Clin Periodontol
40:90, 2013
26. Meloni SM, Tallarico M, Lolli FM, et al: Postextraction socket
preservation using epithelial connective tissue graft vs porcine
collagen matrix. 1-Year results of a randomised controlled trial.
Eur J Oral Implantol 8:39, 2015
27. Brkovic BM, Prasad HS, Rohrer MD, et al: Beta-tricalcium phos-
phate/type I collagen cones with or without a barrier membrane
in human extraction socket healing: Clinical, histologic, histo-
morphometric, and immunohistochemical evaluation. Clin
Oral Investig 16:581, 2012
28. Barone A, Toti P, Piattelli A, et al: Extraction socket healing in hu-
mans after ridge preservation techniques: Comparison between
flapless and flapped procedures in a randomized clinical trial. J
Periodontol 85:14, 2014
29. Hoaglin DR, Lines GK: Prevention of localized osteitis in
mandibular third-molar sites using platelet-rich fibrin. Int J
Dent 2013:875380, 2013
30. Choukroun J, Diss A, Simonpieri A, et al: Platelet-rich fibrin
(PRF): A second-generation platelet concentrate. Part V: Histo-
logic evaluations of PRF effects on bone allograft maturation
in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
101:299, 2006
31. Avila-Ortiz G, Elangovan S, Kramer KW, Blanchette D,
Dawson DV: Effect of alveolar ridge preservation after tooth
extraction: a systematic review and meta-analysis. J Dent Res.
93(10):950–958. https://doi.org/10.1177/0022034514541127,
2014 Oct Epub 2014 Jun 25
32. Bolukbasi N, Ersanlı S, Keklikoglu N, et al: Sinus augmentation
with platelet-rich fibrin in combination with bovine bone graft
versus bovine bone graft in combination with collagen mem-
brane. J Oral Implantol 41:586, 2015
DE ANGELIS ET AL 1815
... Furthermore, the i-PRF preparation process, consisting of venous blood withdrawal followed by a 3-min centrifugation protocol did not result in a significant difference regarding chair time of both treatments. Yet, in accordance with earlier studies demonstrating the potential of PRF to improve soft tissue healing (Ali and Selim 2018;De Angelis et al. 2019;Kızıltoprak and Uslu 2020), significantly higher KT conservation potential was observed in the ADDG + i-PRF compared to the ADDG group 6 months following ARP. This could be attributed to the ability of PRF to stimulate the proliferation of dermal gingival fibroblasts and keratinocytes, and its involvement in the production of extracellular matrix components and collagen 1 (Miron, Fujioka-Kobayashi, Bishara, et al. 2017;). ...
... Similarly, in agreement with earlier investigations, demonstrating the ability of PRF to reduce postoperative pain (De Angelis et al. 2019;Marenzi et al. 2015;Pan et al. 2019), in the present study significantly lower pain scores were evident in the ADDG + i-PRF. These effects could be attributed to the ability of i-PRF to create a three-dimensional fibrin scaffold, which in addition to forming a haemostatic plug, enriches the healing site with a variety of cytokines and growth/differentiation factors, endorsing cellular migration, proliferation, angiogenesis, laying down of fibronectin and collagen-I, tissue formation and epithelization (Bahar, Karakan, and Vurmaz 2024;Choukroun, Aalam, and Miron 2017;Davis et al. 2014;Locatelli et al. 2021;Schär et al. 2015;van Orten, Goetz, and Bilhan 2022). ...
Article
Full-text available
Objective The present trial evaluated the first‐time application of autogenous demineralized dentin graft with injectable platelet‐rich fibrin (ADDG + i‐PRF) versus autogenous demineralized dentin graft (ADDG), in alveolar ridge preservation (ARP) in the maxillary aesthetic zone. Material and Methods Twenty‐two maxillary ( n = 22) non‐molar teeth indicated for extraction were randomized into two groups ( n = 11/group). Extracted teeth were prepared into ADDG, implanted into extraction sockets with or without i‐PRF amalgamation and covered by collagen sponge. Cone‐beam computed tomography scans at baseline and 6 months were compared to assess ridge‐dimensional changes. Keratinized tissue width, patient satisfaction, pain score and chair time were recorded. In the course of dental implant placements at 6 months, bone core biopsies of engrafted sites were obtained and analysed histomorphometrically. Results Reduction in ridge width was 1.71 ± 1.08 and 1.8 ± 1.35 mm, while reduction in ridge height was 1.11 ± 0.76 and 1.8 ± 0.96 mm for ADDG + i‐PRF and ADDG, respectively ( p > 0.05). Significant differences in keratinized tissue width reduction were notable between ADDG + i‐PRF and ADDG (0.12 ± 0.34 and 0.58 ± 0.34 mm respectively; p = 0.008). Postoperative pain scores were significantly lower in ADDG + i‐PRF ( p = 0.012). All patients in the two groups were satisfied with no differences in chair time ( p > 0.05). No differences in total percentage area of newly formed bone, soft tissue or graft particles were observed between the groups ( p > 0.05). Conclusions ADDG alone or in combination with i‐PRF yields similar results regarding ARP clinically, quality of the formed osseous tissues, as well as patients' satisfaction. Yet, the addition of i‐PRF to ADDG tends to preserve the keratinized tissue and lessen postoperative pain.
... A clinical study on socket preservation using three clinical protocols leukocyte and platelet-rich fibrin (L-PRF) alone, L-PRF mixed with a bone xenograft, and bone xenograft alone-stated that the L-PRF group revealed the horizontal dimensional change was 38.3%, while the L-PRF plus bone xenograft group had smaller dimensional changes in the horizontal (18.9%) and vertical (11.42%) dimensions. However, none of the methods utilized in the three groups were able to fully make up for the changes that resulted from tooth extraction [10,11]. ...
... Among the 19 dental specialties, MBFMD aims to diagnose and treat, in a surgical and coadjuvant 5 Contribuciones a Las Ciencias Sociales, São José dos Pinhais, v.17, n.8, p. 01-17, 2024 manner, diseases, traumas, lesions and congenital and acquired anomalies of the masticatory apparatus, its appendages, and associated craniofacial structures [5,6] L-PRF is proving to be a truly outstanding option in the field of oral and maxillofacial surgery. This autologous therapy has emerged as an excellent choice, remarkably enhancing the effectiveness of the healing process [7,8] In addition, its ability to reduce both the intensity of postoperative pain and edema stands out, thus providing a more comfortable experience for patients [9][10][11][12]. In addition, PRF is recognized for its stimulating role in angiogenesis and soft and hard tissue formation, further extending its beneficial scope in surgical and recovery contexts [13]. ...
Article
Full-text available
Introduction: L-PRF is an autologous biomaterial composed of fibrin rich in platelets and leukocytes, which has remarkable potential for promoting tissue regeneration in surgical procedures. Materials and Methods: An exploratory and descriptive bibliometric study was carried out, using a quantitative and statistical approach. The aim was to identify indicators of academic activity related to the applications of platelet- and leukocyte-rich fibrin (L-PRF) in oral and maxillofacial surgery and trauma. Initially, 1811 studies were identified that dealt with the specific applications of L-PRF in the field of (CTBMF). Discussion: There is diversification in the use of L-PRF in dentistry, with decline in some topics and growth in specific and dynamic areas. The analysis reveals disparities in restrictions by country, influenced by the quality of the publications and the relevance of the authors. Conclusion: The applications of platelet- and leukocyte-rich fibrin (L-PRF) in oral and maxillofacial surgery are fundamental and promising.
... Foi admitido que esses materiais de enxerto, embora careçam de propriedades osteoindutoras e osteogênicas têm efeitos osteocondutores 17,19,20 . A questão que tem sido relatada é se a combinação da L-PRF com os enxertos ósseos tem o potencial de figurar como agente osteoindutor 13,17,19,21 . ...
Article
Full-text available
Introdução: A extração do elemento dentário é seguida por mudanças nos tecidos moles e duros que podem comprometer a colocação de implantes. Objetivo: Comparar, por histomorfometria, a eficácia da L-PRF associada ou não ao enxerto sintético HA/β-TCP, no processo de neoformação óssea em alvéolos humanos, após um período de oito semanas das extrações dentárias. Método: Para este estudo piloto, um total de dez participantes foi alocado em dois grupos: G1 (n = 8) para quatro alvéolos maxilares (n = 8) e G2 (n = 2) para quatro alvéolos mandibulares. De cada grupo foram obtidos quatro subgrupos de acordo com o tratamento dos alvéolos (G1, n = 32; G2, n = 8): controle (CTR), apenas exodontias dos elementos dentários, servindo como parâmetro para comparação com os subgrupos experimentais; Autogenous bone (AB), osso autógeno particulado; L-PRF (LPRF), membrana de L-PRF, e; L-PRF + HA/β-TCP (LPRFHA/βTCP), membrana de L-PRF associada ao enxerto sintético. Os participantes passaram por dois procedimentos cirúrgicos: primeira fase de exodontia e enxertia e a segunda, após oito semanas, coleta de material para análise histomorfométrica e instalação dos implantes. Resultados: Seis dos dez participantes iniciais apresentaram idades entre 49 e 68 anos (média 60,83 ± 2,23 anos) e as mulheres foram prevalentes com 66,7% (n = 4). Análises qualitativas de 240 lâminas (24 alvéolos) demonstraram neoformação óssea com diferentes graus de maturidade. O teste de Kolmogorov-Smirnov demonstrou não haver diferença estatisticamente significante entre os subgrupos (p > 0,10). Conclusão: A L-PRF associada ou não ao enxerto sintético HA/β-TCP demonstrou ser um biomaterial previsível para alvéolos humanos pós-extração, havendo uma tendência de a L-PRF associada à biocerâmica reduzir a neoformação óssea para o período de oito semanas.
Article
Platelet-rich fibrin (PRF) has been utilized in implant dentistry for well over a decade owing to its ability to rapidly stimulate tissue angiogenesis. Over the years, much progress has been made to more effectively concentrate platelets and growth factors as well as define their clinical use for the regeneration of both soft and hard tissues. This article will give a brief history of platelet concentrates regarding the advancements made over the years from PRP towards a more autologous three-dimensional scaffold found in PRF. Next, a deep understanding of the years of research leading towards appropriate protocols and methods to best concentrate PRF will be discussed. Lastly, clinical indications and uses of PRF will be demonstrated with case examples highlighting the use of PRF in extraction site management, bone augmentation, as well as in implant dentistry. Case series studies have demonstrated the ability for an extended-PRF-membrane technology lasting 4-6 months from a 1-2 week typical membrane by using the Bio-Heat technology. This allows for the replacement of collagen membranes in standard implant dentistry procedures leading towards a lower-cost, more biological approach to everyday standard implant dentistry.
Article
Aim To assess the efficacy of injectable bone fillers for alveolar ridge preservation (ARP). Materials and Methods The mandibular premolars (P2, P3, P4) were bilaterally assigned to ARP in a total of n = 9 beagle dogs. Each P was decapitated and hemisected under preservation of the mesial (i.e., devitalization and filling with calcium hydroxide) and removal of the distal root. The resulting 6 extraction sockets were randomly allocated to a total of four injectable test materials (i.e., bovine bone particles + porcine collagen, lyophilized materials reconstituted with either blood or saline [T1, T2, T4]; or ready‐to‐use wet material [T3]) and one control material (collagenated bovine bone mineral) (C) as well as one negative control group (N). Primary wound closure was ensured in all test and C groups. At 12 weeks, dissected blocks were prepared for histomorphometrical analyses. Buccal bone height (BBH) was defined as a primary outcome. Lingual bone height (LBH), buccal and lingual bone wall width (BBW and LBW 1, 3 and 5 mm infracrestally), surface area of bone and particles, fibrous tissues, and bone marrows were defined as secondary outcomes. Between‐group comparisons were assessed using ANOVA and Mann–Whitney tests. Results After 12 weeks, all groups were associated with similar BBH values (BBH: 14.1, 14.0, 13.7, 13.8, 14.3 and 114.2 mm in the T1, T2, T3, T4, C and N groups, respectively; p > 0.05 for all between‐group comparisons). The BBW and LBW measurements were comparable among the groups. ARP sites showed a trend towards higher area measurements of bone and particle surfaces compared with the N group (11.5, 11.6, 13.1, 12.5, 9.1 mm ² in T1, T2, T3, T4, C and N groups, respectively). C, T1, T2, T3 and T4 particles were associated with a similar marked grade of osteoconduction and osteointegration within the former extraction socket area. Conclusions Within its limitations, the present study has pointed to the similar efficacy of injectable bone fillers for ARP compared with the particulated bone substitute and negative control.
Article
Bone resorption occurring in the alveolar bone after tooth extraction constitutes one of the most fundamental problems that constitute a cosmetic and functional obstacle to treatment with dental implants or fixed prostheses at the site of extraction. A regenerative injectable complex, albumin and platelet‐rich fibrin (Alb‐PRF), composed of autologous albumin gel and platelet‐rich fibrin (PRF) concentrate, it represents a new strategy that combines the advantages of PRF and albumin gel with slow absorption properties. The current case report included the extraction of a single‐rooted tooth that was extracted atraumatically. Alb‐PRF mixed with alloplast bone graft was used and applied within the socket. The socket was then covered with a piece of gelfoam. The case was followed up for 6 months. Radiographic and clinical measurements were performed, which showed the amount of alteration in both the bone and soft tissue after the extraction. Within the limitations of this case report, we concluded that alveolar ridge preservation using Alb‐PRF mixed with alloplast bone graft has good results.
Article
Full-text available
Aim: The present study was performed to evaluate the use of L-PRF and L-PRF mixed with particulate xenograft as alveolar ridge preservation materials after extraction of a tooth with chronic infection. Evaluation of the buccolingual dimensional changes of alveolar ridge was the primary objective while the secondary objectives were evaluation of the quality of regenerated bone histomorphometrically and assessment of implant stability.
Article
Full-text available
Chronic wounds (VLU: venous leg ulcer, DFU: diabetic foot ulcer, PU: pressure ulcer, or complex wounds) affect a significant proportion of the population. Despite appropriate standard wound care, such ulcers unfortunately may remain open for months or even years. The use of leukocyte- and platelet-rich fibrin (L-PRF) to cure skin ulcers is a simple and inexpensive method, widely used in some countries but unknown or neglected in most others. This auto-controlled prospective cohort study explored and quantified accurately for the first time the adjunctive benefits of topical applications of L-PRF in the management of such refractory ulcers in a diverse group of patients. Forty-four consecutive patients with VLUs (n = 28, 32 wounds: 17 ≤ 10 cm(2) and 15 > 10 cm(2)), DPUs (n = 9, 10 wounds), PUs (n = 5), or complex wounds (n = 2), all refractory to standard treatment for ≥3 months, received a weekly application of L-PRF membranes. L-PRF was prepared following the original L-PRF method developed more than 15 years ago (400g, 12 minutes) using the Intra-Spin L-PRF centrifuge/system and the XPression box kit (Intra-Lock, Boca Raton, FL, USA; the only CE/FDA cleared system for the preparation of L-PRF). Changes in wound area were recorded longitudinally via digital planimetry. Adverse events and pain levels were also registered. All wounds showed significant improvements after the L-PRF therapy. All VLUs ≤ 10 cm(2), all DFUs, as well as the two complex wounds showed full closure within a 3-month period. All wounds of patients with VLUs > 10 cm(2) who continued therapy (10 wounds) could be closed, whereas in the five patients who discontinued therapy improvement of wound size was observed. Two out of the five PUs were closed, with improvement in the remaining three patients who again interrupted therapy (surface evolution from 7.35 ± 4.31 cm(2) to 5.78 ± 3.81 cm(2)). No adverse events were observed. A topical application of L-PRF on chronic ulcers, recalcitrant to standard wound care, promotes healing and wound closure in all patients following the treatment. This new therapy is simple, safe and inexpensive, and should be considered a relevant therapeutic option for all refractory skin ulcers.
Article
Full-text available
Objectives: Research across many fields of medicine now points towards the clinical advantages of combining regenerative procedures with platelet-rich fibrin (PRF). This systematic review aimed to gather the extensive number of articles published to date on PRF in the dental field to better understand the clinical procedures where PRF may be utilized to enhance tissue/bone formation. Materials and methods: Manuscripts were searched systematically until May 2016 and separated into the following categories: intrabony and furcation defect regeneration, extraction socket management, sinus lifting procedures, gingival recession treatment, and guided bone regeneration (GBR) including horizontal/vertical bone augmentation procedures. Only human randomized clinical trials were included for assessment. Results: In total, 35 articles were selected and divided accordingly (kappa = 0.94). Overall, the use of PRF has been most investigated in periodontology for the treatment of periodontal intrabony defects and gingival recessions where the majority of studies have demonstrated favorable results in soft tissue management and repair. Little to no randomized clinical trials were found for extraction socket management although PRF has been shown to significantly decrease by tenfold dry sockets of third molars. Very little to no data was available directly investigating the effects of PRF on new bone formation in GBR, horizontal/vertical bone augmentation procedures, treatment of peri-implantitis, and sinus lifting procedures. Conclusions: Much investigation now supports the use of PRF for periodontal and soft tissue repair. Despite this, there remains a lack of well-conducted studies demonstrating convincingly the role of PRF during hard tissue bone regeneration. Future human randomized clinical studies evaluating the use of PRF on bone formation thus remain necessary. Clinical relevance: PRF was shown to improve soft tissue generation and limit dimensional changes post-extraction, with little available data to date supporting its use in GBR.
Article
Full-text available
Abstract L-PRF (leukocyte- and platelet-rich fibrin) is one of the four families of platelet concentrates for surgical use and is widely used in oral and maxillofacial regenerative therapies. The first objective of this article was to evaluate the mechanical vibrations appearing during centrifugation in four models of commercially available table-top centrifuges used to produce L-PRF and the impact of the centrifuge characteristics on the cell and fibrin architecture of a L-PRF clot and membrane. The second objective of this article was to evaluate how changing some parameters of the L-PRF protocol may influence its biological signature, independently from the characteristics of the centrifuge. In the first part, four different commercially available centrifuges were used to produce L-PRF, following the original L-PRF production method (glass-coated plastic tubes, 400 g force, 12 minutes). The tested systems were the original L-PRF centrifuge (Intra-Spin, Intra-Lock, the only CE and FDA cleared system for the preparation of L-PRF) and three other laboratory centrifuges (not CE/FDA cleared for L-PRF): A-PRF 12 (Advanced PRF, Process), LW-UPD8 (LW Scientific) and Salvin 1310 (Salvin Dental). Each centrifuge was opened for inspection, two accelerometers were installed (one radial, one vertical), and data were collected with a spectrum analyzer in two configurations (full-load or half load). All clots and membranes were collected into a sterile surgical box (Xpression kit, Intra-Lock). The exact macroscopic (weights, sizes) and microscopic (photonic and scanning electron microscopy SEM) characteristics of the L-PRF produced with these four different machines were evaluated. In the second part, venous blood was taken in two groups, respectively, Intra-Spin 9 ml glass-coated plastic tubes (Intra-Lock) and A-PRF 10 ml glass tubes (Process). Tubes were immediately centrifuged at 2700 rpm (around 400 g) during 12 minutes to produce L-PRF or at 1500 rpm during 14 minutes to produce A-PRF. All centrifugations were done using the original L-PRF centrifuge (Intra-Spin), as recommended by the two manufacturers. Half of the membranes were placed individually in culture media and transferred in a new tube at seven experimental times (up to 7 days). The releases of transforming growth factor β-1 (TGFβ-1), platelet derived growth factor AB (PDGF-AB), vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2) were quantified using ELISA kits at these seven experimental times. The remaining membranes were used to evaluate the initial quantity of growth factors of the L-PRF and A-PRF membranes, through forcible extraction. Very significant differences in the level of vibrations at each rotational speed were observed between the four tested centrifuges. The original L-PRF centrifuge (Intra-Spin) was by far the most stable machine in all configurations and always remained under the threshold of resonance, unlike the three other tested machines. At the classical speed of production of L-PRF, the level of undesirable vibrations on the original centrifuge was between 4.5 and 6 times lower than with other centrifuges. Intra-Spin showed the lowest temperature of the tubes. A-PRF and Salvin were both associated with a significant increase in temperature in the tube. Intra-Spin produced the heaviest clot and quantity of exudate among the four techniques. A-PRF and LW produced much lighter, shorter and narrower clots and membranes than the two other centrifuges. Light microscopy analysis showed relatively similar features for all L-PRF types (concentration of cell bodies in the first half). However, SEM illustrated considerable differences between samples. The original Intra-Spin L-PRF showed a strongly polymerized thick fibrin matrix and all cells appeared alive with a normal shape, including the textured surface aspect of activated lymphocytes. The A-PRF, Salvin and LW PRF-like membranes presented a lightly polymerized slim fibrin gel and most of the visible cell bodies appeared destroyed (squashed or shrunk). In the second part of this study, the slow release of the three tested growth factors from original L-PRF membranes was significantly stronger (more than twice stronger, p<0.001) at all experimental times than the release from A-PRF membranes. No trace of BMP2 could be detected in the A-PRF. A slow release of BMP2 was detected during at least 7 days in the original L-PRF. Moreover, the original L-PRF clots and membranes (produced with 9 mL blood) were always significantly larger than the A-PRF (produced with 10 mL blood). The A-PRF membranes dissolved in vitro after less than 3 days, while the L-PRF membrane remained in good shape during at least 7 days. Each centrifuge has its clear own profile of vibrations depending on the rotational speed, and the centrifuge characteristics are directly impacting the architecture and cell content of a L-PRF clot. This result may reveal a considerable flaw in all the PRP/PRF literature, as this parameter was never considered. The original L-PRF clot (Intra-Spin) presented very specific characteristics, which appeared distorted when using centrifuges with a higher vibration level. A-PRF, LW and Salvin centrifuges produced PRF-like materials with a damaged and almost destroyed cell population through the standard protocol, and it is therefore impossible to classify these products in the L-PRF family. Moreover, when using the same centrifuge, the original L-PRF protocol allowed producing larger clots/membranes and a more intense release of growth factors (biological signature at least twice stronger) than the modified A-PRF protocol. Both protocols are therefore significantly different, and the clinical and experimental results from the original L-PRF shall not be extrapolated to the A-PRF. Finally, the comparison between the total released amounts and the initial content of the membrane (after forcible extraction) highlighted that the leukocytes living in the fibrin matrix are involved in the production of significant amounts of growth factors. The centrifuge characteristics and centrifugation protocols impact significantly and dramatically the cells, growth factors and fibrin architecture of L-PRF.
Article
Full-text available
PurposeThe aim of this study was to analyze systematically the influence of the relative centrifugation force (RCF) on leukocytes, platelets and growth factor release within fluid platelet-rich fibrin matrices (PRF). Materials and methodsSystematically using peripheral blood from six healthy volunteers, the RCF was reduced four times for each of the three experimental protocols (I–III) within the spectrum (710–44 g), while maintaining a constant centrifugation time. Flow cytometry was applied to determine the platelets and leukocyte number. The growth factor concentration was quantified 1 and 24 h after clotting using ELISA. ResultsReducing RCF in accordance with protocol-II (177 g) led to a significantly higher platelets and leukocytes numbers compared to protocol-I (710 g). Protocol-III (44 g) showed a highly significant increase of leukocytes and platelets number in comparison to -I and -II. The growth factors’ concentration of VEGF and TGF-β1 was significantly higher in protocol-II compared to -I, whereas protocol-III exhibited significantly higher growth factor concentration compared to protocols-I and -II. These findings were observed among 1 and 24 h after clotting, as well as the accumulated growth factor concentration over 24 h. DiscussionBased on the results, it has been demonstrated that it is possible to enrich PRF-based fluid matrices with leukocytes, platelets and growth factors by means of a single alteration of the centrifugation settings within the clinical routine. Conclusions We postulate that the so-called low speed centrifugation concept (LSCC) selectively enriches leukocytes, platelets and growth factors within fluid PRF-based matrices. Further studies are needed to evaluate the effect of cell and growth factor enrichment on wound healing and tissue regeneration while comparing blood concentrates gained by high and low RCF.
Article
Full-text available
Aim: To analyse the regenerative potential of Leucocyte- and Platelet Rich Fibrin (L-PRF) during periodontal surgery. Materials and methods: An electronic and hand search were conducted in three databases. Only randomised clinical trials were selected and no follow-up limitation was applied. Pocket depth (PD), clinical attachment level (CAL), bone fill, keratinized tissue width (KTW), recession reduction, and root coverage (%) were considered as outcome. When possible, meta-analysis was performed. Results: Twenty-four articles fulfilled the inclusion and exclusion criteria. Three subgroups were created: intrabony defects (IBDs), furcation defects, and periodontal plastic surgery. Meta-analysis was performed in all the subgroups. Significant PD reduction (1.1±0.5mm, p<0.001), CAL gain (1.2±0.6mm, p<0.001), and bone fill (1.7±0.7mm, p<0.001) were found when comparing L-PRF to open flap debridement (OFD) in IBDs. For furcation defects, significant PD reduction (1.9±1.5mm, p=0.01), CAL gain (1.3±0.4mm, p<0.001), and bone fill (1.5±0.3mm, p<0.001) were reported when comparing L-PRF to OFD. When L-PRF was compared to a connective tissue graft, similar outcomes were recorded for PD reduction (0.2±0.3mm, p>0.05), CAL gain (0.2±0.5mm, p>0.05), KTW (0.3±0.4mm, p>0.05), and recession reduction (0.2±0.3mm, p>0.05). Conclusions: L-PRF enhances periodontal wound healing. This article is protected by copyright. All rights reserved.
Article
Full-text available
Background: Over the past decade, the use of leukocyte platelet rich fibrin (L-PRF) has gained tremendous momentum in regenerative dentistry as a low-cost fibrin matrix utilized for tissue regeneration. In this study, we characterized how centrifugation speed (G-force) along with centrifugation time influence growth factor release from fibrin clots, as well as the cellular activity of gingival fibroblasts exposed to each PRF matrix. Methods: Standard L-PRF served as a control (2700rpm-12 minutes). Two test groups utilizing low-speed (1300rpm-14 min termed advanced-PRF, A-PRF) and low-speed+time (1300rpm-8 min; A-PRF+) were investigated. Each PRF matrix was tested for growth factor release up to 10 days (8 donor samples) as well as biocompatibility and cellular activity. Results: The low speed concept (A-PRF, A-PRF+) demonstrated a significant increase in growth factor release of PDGF, TGF- β1, EGF and IGF with A-PRF+ being highest of all groups. While all PRF formulations were extremely biocompatible due to their autogenous sources, both A-PRF and A-PRF+ demonstrated significantly higher levels of human fibroblast migration and proliferation when compared to L-PRF. Furthermore, gingival fibroblasts cultured with A-PRF+ demonstrated significantly higher mRNA levels of PDGF, TGF-β and collagen1 at either 3 or 7 days. Conclusions: The findings from the present study demonstrate that modifications to centrifugation speed and time with the low-speed concept was shown to favor an increase in growth factor release from PRF clots which in turn may directly influence tissue regeneration by increasing fibroblast migration, proliferation and collagen mRNA levels. Future animal and clinical studies are now necessary.
Article
Full-text available
Objectives The use of platelet concentrates has gained increasing awareness in recent years for regenerative procedures in modern dentistry. The aim of the present study was to compare growth factor release over time from platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and a modernized protocol for PRF, advanced-PRF (A-PRF). Materials and methods Eighteen blood samples were collected from six donors (3 samples each for PRP, PRF, and A-PRF). Following preparation, samples were incubated in a plate shaker and assessed for growth factor release at 15 min, 60 min, 8 h, 1 day, 3 days, and 10 days. Thereafter, growth factor release of PDGF-AA, PDGF-AB, PDGF-BB, TGFB1, VEGF, EGF, and IGF was quantified using ELISA. Results The highest reported growth factor released from platelet concentrates was PDGF-AA followed by PDGF-BB, TGFB1, VEGF, and PDGF-AB. In general, following 15–60 min incubation, PRP released significantly higher growth factors when compared to PRF and A-PRF. At later time points up to 10 days, it was routinely found that A-PRF released the highest total growth factors. Furthermore, A-PRF released significantly higher total protein accumulated over a 10-day period when compared to PRP or PRF. Conclusion The results from the present study indicate that the various platelet concentrates have quite different release kinetics. The advantage of PRP is the release of significantly higher proteins at earlier time points whereas PRF displayed a continual and steady release of growth factors over a 10-day period. Furthermore, in general, it was observed that the new formulation of PRF (A-PRF) released significantly higher total quantities of growth factors when compared to traditional PRF. Clinical relevance Based on these findings, PRP can be recommended for fast delivery of growth factors whereas A-PRF is better-suited for long-term release.
Article
Platelet-rich fibrin is a blood concentrate system used for soft tissue and bone tissue regeneration. In the last decade, platelet rich fibrin (PRF) has been widely used in different indication fields, particularly in oral and maxillofacial surgery. This review is aimed to investigate the level of scientific evidence of published articles related to the use of PRF for bone and soft tissue regeneration in dentistry and maxillofacial surgery. An electronic literature research using the biomedical search engine "National Library of Medicine" (PubMed-MEDLINE) was performed in May 2017. A total of 392 articles were found, 72 of which were classified for each indication field. When comparing PRF with biomaterials vs biomaterial alone in sinus lift (5 studies; IIa), no statistically significant differences were detected. Socket preservation and ridge augmentation using PRF significantly enhanced new bone formation compared to healing without PRF (seven studies Ib, IIa, IIb). Reepithelialization and bone regeneration was achieved in 96 of 101 patients diagnosed with medication-related osteonecrosis of the jaw (5 studies, III). In periodontology, PRF alone (six studies; Ib, IIa, IIb) or its combination with biomaterials (six studies; Ib, IIa, IIb) significantly improved the pocket depth and attachment loss compared to a treatment without PRF. Over 70% of the patients were part of studies with a high level of scientific evidence (randomized and controlled prospective studies). This published evidence, with a high scientific level, showed that PRF (38 articles) is a beneficial tool that significantly improves bone and soft tissue regeneration. However, the clinical community requires a standardization of PRF protocols to further examine the benefit of PRF in bone and soft tissue regeneration in reproducible studies, with a higher scientific level of evidence.
Article
In the esthetic zone, in the case of tooth extraction, the clinician is often confronted with a challenge regarding the optimal decision-making process for providing a solution using dental implants. This is because, after tooth extraction, alveolar bone loss and structural and compositional changes of the covering soft tissues, as well as morphological alterations, can be expected. Ideally, the therapeutic plan starts before tooth extraction and it offers three options: spontaneous healing of the extraction socket; immediate implant placement; and techniques for preserving the alveolar ridge at the site of tooth removal. The decision-making process mainly depends on: (i) the chosen time-point for implant placement and the ability to place a dental implant; (ii) the quality and quantity of soft tissue in the region of the extraction socket; (iii) the remaining height of the buccal bone plate; and (iv) the expected rates of implant survival and success. Based on scientific evidence, three time-periods for alveolar ridge preservation are described in the literature: (i) soft-tissue preservation with 6–8 weeks of healing after tooth extraction (for optimization of the soft tissues); (ii) hard- and soft-tissue preservation with 4–6 months of healing after tooth extraction (for optimization of the hard and soft tissues); and (iii) hard-tissue preservation with > 6 months of healing after tooth extraction (for optimization of the hard tissues).
Article
Aim: To investigate the influence of the use L-PRF as a socket filling material and its ridge preservation properties. Materials and methods: Twenty two patients in need of single bilateral and closely symmetrical tooth extractions in the maxilla or mandible were included in a split-mouth RCT. Treatments were randomly assigned (L-PRF socket filling vs. natural healing). CBCT scans were obtained after tooth extraction and 3 months. Scans were evaluated by superimposition using the original DICOM data. Mean ridge width differences between timepoints were measured at 3 levels below the crest on both the buccal and lingual sides (crest -1mm (primary outcome variable), -3mm and -5mm). Results: Mean vertical height changes at the buccal were -1,5 mm (± 1,3) for control sites and 0,5 mm (± 2,3) for test sites (p<0.005). At the buccal side, control sites values were respectively, -2,1 (±2,5), -0,3mm (±0,3) (p<0,005) and -0,1mm (±0,0), test sites values were respectively -0,6mm (±2,2) (p<0,005), -0,1mm (±0,3) and 0,0mm (±0,1) Significant differences (p<0,005) were found for total width reduction between test (-22,84%) and control sites (-51,92%) at 1mm below crest level. Significant differences were found for socket fill (visible mineralised bone) between test (94,7%) and control sites (63,3%). Conclusion: The use of L-PRF as a socket filling material in order to achieve preservation of horizontal and vertical ridge dimension at 3 months after tooth extraction is beneficial. This article is protected by copyright. All rights reserved.